Showing results (71-80 of 79) with videos related to
Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 79 results.
Hepatology (Baltimore, Md.)|August 2, 2001
A randomized, double-blind trial comparing pegylated interferon alfa-2b to interferon alfa-2b as initial treatment for chronic hepatitis CK L Lindsay, C Trepo, T Heintges, et al.Hepatology (Baltimore, Md.)|February 1, 1997
Treatment of chronic hepatitis C with interferon alfa-n3: a multicenter, randomized, open-label trialD M Simon, S C Gordon, M M Kaplan, et al.Alimentary Pharmacology & Therapeutics|September 20, 2016
Distribution of disease phase, treatment prescription and severe liver disease among 1598 patients with chronic hepatitis B in the Chronic Hepatitis Cohort Study, 2006-2013P R Spradling, J Xing, L B Rupp, et al.Journal of Viral Hepatitis|May 18, 2016
Higher all-cause hospitalization among patients with chronic hepatitis C: the Chronic Hepatitis Cohort Study (CHeCS), 2006-2013E H Teshale, J Xing, A Moorman, et al.Journal of Viral Hepatitis|December 22, 1999
Thymosin alpha1 treatment of chronic hepatitis B: results of a phase III multicentre, randomized, double-blind and placebo-controlled studyM G Mutchnick, K L Lindsay, E R Schiff, et al.Journal of Viral Hepatitis|February 26, 2018
Impact of sustained virologic response on risk of type 2 diabetes among hepatitis C patients in the United StatesJ Li, T Zhang, S C Gordon, et al.Alimentary Pharmacology & Therapeutics|May 29, 2013
Adherence to assigned dosing regimen and sustained virological response among chronic hepatitis C genotype 1 patients treated with boceprevir plus peginterferon alfa-2b/ribavirinS C Gordon, E M Yoshida, E J Lawitz, et al.Journal of Viral Hepatitis|July 2, 2013
Long-term clearance of hepatitis C virus following interferon α-2b or peginterferon α-2b, alone or in combination with ribavirinM P Manns, P J Pockros, G Norkrans, et al.HLA|July 12, 2017
HLA haplotypes in primary sclerosing cholangitis patients of admixed and non-European ancestryE K K Henriksen, M K Viken, M Wittig, et al.Pageof 8